tiprankstipranks
Advertisement
Advertisement

FDMT Stock Latest News

B. Riley views EyePoint study miss as positive for 4D Molecular
The FlyB. Riley views EyePoint study miss as positive for 4D Molecular
6d ago
EYPT
FDMT
4D Molecular reports Q2 EPS ($1.04), consensus ($1.02)
PremiumThe Fly
4D Molecular reports Q2 EPS ($1.04), consensus ($1.02)
7d ago
FDMT
4D Molecular price target lowered to $32 from $33 at Goldman Sachs
PremiumThe Fly
4D Molecular price target lowered to $32 from $33 at Goldman Sachs
7d ago
FDMT
Analyst Reiterates Buy on 4D Molecular Therapeutics, Maintains $36 Price Target as 4D-150 Advances Through Late-Stage Trials
PremiumRatings
Analyst Reiterates Buy on 4D Molecular Therapeutics, Maintains $36 Price Target as 4D-150 Advances Through Late-Stage Trials
10d ago
FDMT
Roblox downgraded, Quanta Services upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Roblox downgraded, Quanta Services upgraded: Wall Street’s top analyst calls
24d ago
IP
BSX
4D Molecular initiated with a Buy at B. Riley
PremiumThe Fly4D Molecular initiated with a Buy at B. Riley
24d ago
LLY
FDMT
4D Molecular Therapeutics Posts Strong 4D-150 Trial Results
Premium
Company Announcements
4D Molecular Therapeutics Posts Strong 4D-150 Trial Results
1M ago
8K
FDMT
4D-150’s Durable Efficacy and Clean Safety Profile Support Buy Rating and Unchanged $36 Price Target
Premium
Ratings
4D-150’s Durable Efficacy and Clean Safety Profile Support Buy Rating and Unchanged $36 Price Target
1M ago
FDMT
4D Molecular Therapeutics Buy Rating Reaffirmed on 4D-150 Pivotal Trial Momentum; Price Target Maintained at $36
PremiumRatings
4D Molecular Therapeutics Buy Rating Reaffirmed on 4D-150 Pivotal Trial Momentum; Price Target Maintained at $36
2M ago
FDMT
4D Molecular Therapeutics Secures $200 Million Loan Facility
PremiumCompany Announcements
4D Molecular Therapeutics Secures $200 Million Loan Facility
2M ago
8K
FDMT
4D Molecular completes enrollment in 4FRONT-2 trial
PremiumThe Fly
4D Molecular completes enrollment in 4FRONT-2 trial
2M ago
FDMT
4D Molecular Therapeutics Stockholders Back Directors and Governance
PremiumCompany Announcements
4D Molecular Therapeutics Stockholders Back Directors and Governance
2M ago
8K
FDMT
Analyst Reiterates Buy on 4D Molecular Therapeutics as Wet AMD Gene Therapy Advances, Keeps $36 Price Target Unchanged
PremiumRatingsAnalyst Reiterates Buy on 4D Molecular Therapeutics as Wet AMD Gene Therapy Advances, Keeps $36 Price Target Unchanged
3M ago
FDMT
Daniel Giraldo Reiterates Buy on 4D Molecular Therapeutics, Citing Strong 4D-150 Progress and Undervalued Upside vs. $29 Price Target
Premium
Ratings
Daniel Giraldo Reiterates Buy on 4D Molecular Therapeutics, Citing Strong 4D-150 Progress and Undervalued Upside vs. $29 Price Target
4M ago
FDMT
4D Molecular price target lowered to $33 from $38 at Goldman Sachs
Premium
The Fly
4D Molecular price target lowered to $33 from $38 at Goldman Sachs
4M ago
FDMT
4D Molecular files $400M mixed securities shelf
PremiumThe Fly
4D Molecular files $400M mixed securities shelf
4M ago
FDMT
4D Molecular reports Q1 EPS ($1.01), consensus ($1.00)
PremiumThe Fly
4D Molecular reports Q1 EPS ($1.01), consensus ($1.00)
4M ago
FDMT
4D Molecular price target lowered to $23 from $45 at Evercore ISI
PremiumThe Fly
4D Molecular price target lowered to $23 from $45 at Evercore ISI
4M ago
FDMT
4D Molecular Therapeutics Consolidates Financial Leadership Under New Role
PremiumCompany Announcements
4D Molecular Therapeutics Consolidates Financial Leadership Under New Role
5M ago
8K
FDMT
4D Molecular assumed with a Buy at Jefferies
PremiumThe Fly4D Molecular assumed with a Buy at Jefferies
5M ago
FDMT
Reimbursement and Pricing Pressures Threaten Commercial Outlook for 4D Molecular Therapeutics’ Gene Therapies
Premium
Company Announcements
Reimbursement and Pricing Pressures Threaten Commercial Outlook for 4D Molecular Therapeutics’ Gene Therapies
5M ago
FDMT
4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings Cheat Sheet
6M ago
FDMT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >